Federal Circuit Lifts Injunction, Clearing Path for Sun Pharmaceutical’s Alopecia Treatment Launch

The United States Court of Appeals for the Federal Circuit vacated an injunction on Wednesday, giving Sun Pharmaceutical the green light to launch its alopecia drug, Leqselvi. This decision came swiftly, less than an hour after oral arguments were presented. The judges showed limited sympathy towards the patent holder, who was still years away from bringing its own drug to market. For a more detailed account, you can review the original article on Law360.